Topics
CME/CE
Editorial Board
Etanercept shows safety, efficacy through five years
Washington -- A new study presented in poster form at the recent AAD meeting concludes that etanercept continues to post an excellent record for the treatment of rheumatoid arthritis. The drug maintains its safety profile and clinical efficacy for treatment durations of more than five years.
Related Videos
Related Content
